Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,944,045 papers from all fields of science
Search
Sign In
Create Free Account
RS 82856
Known as:
RS-82856
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
lixazinone
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
Electrochemical evaluation of the interaction between ascorbic acid and the cardiotonic drug RS-82856.
G. Visor
,
L. Lin
,
R. Kenley
,
M. C. Venuti
,
R. Alvarez
Drug design and delivery
1987
Corpus ID: 45840499
The solution phase interaction between ascorbic acid and the cardiotonic drug N-cyclohexyl-N-methyl-4(7-oxy 1,2,3,5…
Expand
1987
1987
Parenteral formulation development for the positive inotropic agent RS-82856: solubility and stability enhancement through complexation and lyophilization.
G. Visor
,
L. Lin
,
E. Benjamin
,
R. Strickley
,
L. Gu
Journal of parenteral science and technology : a…
1987
Corpus ID: 28333237
Parenteral formulation development for the positive inotropic agent N-cyclohexyl-N-methyl-4 (7-oxy-l,2,3,5-Tetrahydroimidazo[2,1…
Expand
1987
1987
RS-82856, a selective phosphodiesterase inhibitor with inotropic, afterload reduction and antithrombotic properties.
A. Strosberg
,
L. Johnson
,
+5 authors
M. C. Venuti
Proceedings of the Western Pharmacology Society
1987
Corpus ID: 38842351